Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Status Epilepticus

Open-data reference.

11 US clinical trials · 9 currently recruiting

Active & Recent Trials

RECRUITING 20,000 participants

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

University of New Mexi

NCT05140265

RECRUITING 5,000 participants

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

University of Maryland, Baltimore

NCT04189471

RECRUITING Phase 3 770 participants

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

University of Virginia

NCT06907173

RECRUITING 512 participants

Augmented Renal Clearance in Neurocritical Care

University of Alberta

NCT07410624

RECRUITING NA 450 participants

Improving Status Epilepticus Treatment Times

Nationwide Children's Hospital

NCT06194747

RECRUITING NA 420 participants

Simulation Trial of Telemedical Support for Paramedics

Boston Medical Center

NCT06441760

RECRUITING 60 participants

Rapid-Response EEG in Children With Suspected Status Epilepticus

Children's Hospital at Montefiore

NCT06564662

RECRUITING Phase 2 52 participants

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

University of California, San Francis

NCT06401707

RECRUITING Phase 2 30 participants

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

University of California, San Francis

NCT05851391

COMPLETED Phase 3 1,023 participants

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

Robert Silbergleit

NCT00809146

COMPLETED NA 17 participants

Seizure Rescue Medication: Caregiver Education in a Simulation Setting

Boston Children's Hospital

NCT03562351

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Status Epilepticus Trial Landscape

ClinicalTrials.gov lists 11 US studies indexed under Status Epilepticus, and 9 of those are currently open to recruitment — roughly 82% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Status Epilepticus shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Status Epilepticus is led by University of California, San Francis with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Status Epilepticus?

PlainTrial tracks 11 US clinical trials for Status Epilepticus, of which 9 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Status Epilepticus?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →